OPC, Al's done wonders in his life few would ever dream of. I'll cut him some slack in what will be his last round-up. You apparently have the goods on him and want his hide! Or at least to stop lieing to us. I realize Al gets carried away, he shouldn't, and maybe he shouldn't be so much the face of the Company at his age.

Here's what you wrote re the financing:

"As to leveraging the 200mil order, not sure what you found so difficult. I tried to explain it a couple different ways. So I'll try one more time. They have money. We need it. However we can't sell product right now. They loan us the money and it's secured by fulfillment of an order. It just happens that the customer and lender are the same person. Very little risk as the truth of the matter is that the FDA can't prevent the sale of drugs in foreign countries were the fda to actually look into the loan."

So, why not just sell it to this third party, then, and take the money, done deal? The FDA can't stop them, if it's a foreign national or country, and that way the foreign interest can start to use the product. Are you saying make the transaction look like a loan and fool the FDA, lest they get upset with MNKD? Because I have to assume that the moment the FDA either says "yea" or "nea" the order will be shipped (the foreign interest has decided to use the problem irrespective of the FDA's ultimate decision). There is no entity that will "loan" money (disguised and, apparently in you scenario, delayed purchase) on an order to be delivered in the future contingent on FDA approval, thus, the reason to structure it in the way you present has to be because MNKD and the foreign interest have agreed to not upset the FDA with an outright sale. Are the FDA fools, and won't notice what is going on? And isn't what you're suggesting here very much like what you are criticizing MNKD management for - deceit?